Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-001428
Filing Date
2015-08-06
Accepted
2015-08-05 18:16:44
Documents
13
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcon-20150630x10q.htm 10-Q 1243626
2 EX-31.1 tcon-20150630ex311c75ed5.htm EX-31.1 11536
3 EX-31.2 tcon-20150630ex3124ea8ee.htm EX-31.2 11128
4 EX-32.1 tcon-20150630ex321cf8bf9.htm EX-32.1 6742
5 EX-32.2 tcon-20150630ex322b6a6e3.htm EX-32.2 6841
6 GRAPHIC tcon-20150630x10qg001.gif GRAPHIC 82445
7 GRAPHIC tcon-20150630x10qg002.gif GRAPHIC 51362
  Complete submission text file 0001558370-15-001428.txt   4233785

Data Files

Seq Description Document Type Size
8 EX-101.INS tcon-20150630.xml EX-101.INS 711933
9 EX-101.SCH tcon-20150630.xsd EX-101.SCH 28837
10 EX-101.CAL tcon-20150630_cal.xml EX-101.CAL 35687
11 EX-101.DEF tcon-20150630_def.xml EX-101.DEF 104631
12 EX-101.LAB tcon-20150630_lab.xml EX-101.LAB 288791
13 EX-101.PRE tcon-20150630_pre.xml EX-101.PRE 198909
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36818 | Film No.: 151030371
SIC: 2836 Biological Products, (No Diagnostic Substances)